Literature DB >> 27888224

Massive haemolysis, gas-forming liver abscess and sepsis due to Clostridium perfringens bacteraemia.

Rafael García Carretero1, Marta Romero Brugera2, Oscar Vazquez-Gomez3, Noelia Rebollo-Aparicio4.   

Abstract

Clostridial soft tissue infections are infrequent, but can be life-threatening when associated with certain underlying conditions, such as immunosuppression or malignancy. When bacteraemia occurs, it can be accompanied by haemolysis. Only surgical removal of the focus of infection and early onset of antibiotic therapy can prevent a very poor outcome. We describe the case of a man aged 65 years who presented with sepsis, haemolysis and rapid worsening. The identification of a gas-forming liver abscess, the early percutaneous drainage and the prompt initiation of antibiotic treatment were the key factors in the outcome of this patient. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27888224      PMCID: PMC5174861          DOI: 10.1136/bcr-2016-218014

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  A case of gas-forming liver abscess with diabetes mellitus.

Authors:  Tetsuya Tatsuta; Toyohito Wada; Daisuke Chinda; Kiyoto Tsushima; Yoshio Sasaki; Tadashi Shimoyama; Shinsaku Fukuda
Journal:  Intern Med       Date:  2011-10-15       Impact factor: 1.271

Review 2.  Clostridium perfringens septicaemia with massive intravascular haemolysis: a case report and review of the literature.

Authors:  C C van Bunderen; M K Bomers; E Wesdorp; P Peerbooms; J Veenstra
Journal:  Neth J Med       Date:  2010-09       Impact factor: 1.422

Review 3.  Clinical features of clostridial bacteremia: a review from a rural area.

Authors:  P M Rechner; W A Agger; K Mruz; T H Cogbill
Journal:  Clin Infect Dis       Date:  2001-06-22       Impact factor: 9.079

4.  Clostridium perfringens gas gangrene at a wrist intravenous line insertion.

Authors:  Catherine Determann; Craig Andrew Walker
Journal:  BMJ Case Rep       Date:  2013-10-09

5.  Massive intravascular hemolysis from Clostridium perfringens septicemia: a review.

Authors:  Tracey G Simon; Joanna Bradley; Adisa Jones; Gerardo Carino
Journal:  J Intensive Care Med       Date:  2013-09-09       Impact factor: 3.510

6.  Epidemiological and pathobiological profiles of Clostridium perfringens infections: review of consecutive series of 33 cases over a 13-year period.

Authors:  Yuji Shindo; Yoh Dobashi; Toshiyasu Sakai; Chie Monma; Hiroyuki Miyatani; Yukio Yoshida
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Clinical and epidemiological features of Clostridium perfringens bacteremia: a review of 18 cases over 8 year-period in a tertiary care center in metropolitan Tokyo area in Japan.

Authors:  Hiroshi Fujita; Shigeko Nishimura; Saiko Kurosawa; Itsuo Akiya; Fukumi Nakamura-Uchiyama; Kenji Ohnishi
Journal:  Intern Med       Date:  2010-11-15       Impact factor: 1.271

Review 8.  Hepatic abscess: Diagnosis and management.

Authors:  S Lardière-Deguelte; E Ragot; K Amroun; T Piardi; S Dokmak; O Bruno; F Appere; A Sibert; C Hoeffel; D Sommacale; R Kianmanesh
Journal:  J Visc Surg       Date:  2015-03-12       Impact factor: 2.043

9.  Gas-forming liver abscess associated with rapid hemolysis in a diabetic patient.

Authors:  Miwa Kurasawa; Takashi Nishikido; Junko Koike; Shin-Ichi Tominaga; Hiroyuki Tamemoto
Journal:  World J Diabetes       Date:  2014-04-15
  9 in total
  3 in total

1.  Fulminant Haemolysis Following Endoscopic Retrograde Cholangiopancreatography.

Authors:  Mário Bibi; Susana Viana; Cátia Leitão; Rui Moço; Yuliana O Eremina
Journal:  Eur J Case Rep Intern Med       Date:  2021-09-01

2.  Clostridium paraputrificum septicemia and liver abscess.

Authors:  Yong K Kwon; Faiqa A Cheema; Bejon T Maneckshana; Caroline Rochon; Patricia A Sheiner
Journal:  World J Hepatol       Date:  2018-03-27

3.  Clostridium perfringens bloodstream infection secondary to acute pancreatitis: A case report.

Authors:  Ming Li; Ning Li
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.